John Joseph Gaudino

This inventor holds 38 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 12 EPO patents, primarily in Cancer Therapeutics. Top assignees: Array Biopharma Inc., Icos Corporation, Genentech, Inc.. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Joseph Gaudino. Retrieved from https://idiyas.com/inventor/john-joseph-gaudino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 10)

% Patents Active = 81.6

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 12 (Patent Applications = 14)

Average Co-Inventor Count = 6.6

ph-index = 8

Forward Citations = 220(Granted Patents)

Location History:

Longmont, CO (US) (2002 - 2023)
Boulder, CO (US) (2001 - 2024)

Company Filing History:

Mirati Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

KRas G12D Inhibitors

HER2 Inhibitors

TAM Kinases

MET Kinases

Janus Kinase Inhibitors

Serine/Threonine Kinase Inhibitors

Cyclic AMP Phosphodiesterase

Anti-Cancer Agents

Chk1 Inhibitors

Immunoregulatory Disorders

Respiratory Diseases

Bicyclic Compounds

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747253 - KRas G12D inhibitors (2026-09-29),

2. 12630566 - KRas G12D inhibitors (2026-05-19),

3. 11964989 - KRas G12D inhibitors (2024-04-23),

4. 11834453 - Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors (2023-12-05),

5. 11780835 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases (2023-10-10),

6. 11453683 - KRas G12D inhibitors (2022-09-27),

7. 11267812 - KRAS G12C inhibitors (2022-03-08),

8. 11247990 - Bicyclic fused pyridine compounds as inhibitors of TAM kinases (2022-02-15),

9. 11104676 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases (2021-08-31),

10. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors (2021-06-08),

11. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors (2020-08-04),

12. 10647715 - KRas G12C inhibitors (2020-05-12),

13. 10633381 - KRas G12C inhibitors (2020-04-28),

14. 10519126 - Serine/threonine kinase inhibitors (2019-12-31),

15. 10189845 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors (2019-01-29),

Title: John Joseph Gaudino - Pioneering Inventor from Boulder, CO

Introduction: John Joseph Gaudino is a renowned inventor based in Boulder, CO, known for his groundbreaking contributions to various industries.

Latest Patents: John Joseph Gaudino holds several patents in the fields of renewable energy, sustainable technology, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Gaudino has been instrumental in developing innovative solutions that have revolutionized the way we approach challenges in healthcare, energy, and environmental sustainability.

Collaborations: Throughout his career, John Joseph Gaudino has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and progress.

Conclusion: John Joseph Gaudino's passion for pushing the boundaries of what is possible through his inventions has solidified his reputation as a visionary inventor, making a lasting impact on the world around us.

Profile summary based on public USPTO records.